These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12148385)

  • 41. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
    Wilson R; Macklin-Doherty A
    Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
    Miravitlles M; Ros F; Cobos A; Kubin R; Tillotson G
    Int J Clin Pract; 2001 Sep; 55(7):437-41. PubMed ID: 11594251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute exacerbations of chronic bronchitis. Preventing treatment failures and early reinfection.
    Verghese A; Ismail HM
    Postgrad Med; 1994 Dec; 96(8):75-6, 79-82, 87-9. PubMed ID: 7991479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute exacerbation of chronic bronchitis: expanding short-course therapy.
    Martinez FJ
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 3():S156-63. PubMed ID: 16543077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
    Meister R; Wittig T; Beuscher N; de Mey C
    Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic therapy of exacerbations of chronic bronchitis.
    Niederman MS
    Semin Respir Infect; 2000 Mar; 15(1):59-70. PubMed ID: 10749551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
    Kleckow M
    Fortschr Med; 1991 Jul; 109(22):450-4. PubMed ID: 1937326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
    Kiesslich R; Will D; Hahn M; Nafe B; Genitsariotis R; Mäurer M; Jung M
    Z Gastroenterol; 2003 Jan; 41(1):5-10. PubMed ID: 12541165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
    Li J; Zheng JP; Yuan JP; Zeng GQ; Zhong NS; Lin CY
    Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The importance of fluoroquinolones in treating pneumonia in the elderly].
    Belousov IuB; Efremenkova OV; Sokolov AV; Tishenkova IF
    Antibiot Khimioter; 1999; 44(12):23-6. PubMed ID: 10687030
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of antibiotics in the management of acute exacerbation of chronic bronchitis (answers to some commonly asked questions).
    Skudlarska BA; Scott GC
    Mo Med; 1992 May; 89(5):289-93. PubMed ID: 1608387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].
    Llor C; Naberan K; Cots JM; Molina J; Ros F; Miravitlles M;
    Arch Bronconeumol; 2006 Apr; 42(4):175-82. PubMed ID: 16735014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bacterial exacerbation of chronic bronchitis: massive or long term antibiotic therapy?].
    Bürgi H
    Schweiz Med Wochenschr; 1970 Oct; 100(43):1846-8. PubMed ID: 5003997
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
    Nouvet G; Benmessaoud K
    Drugs; 1995; 49 Suppl 2():423-5. PubMed ID: 8549386
    [No Abstract]   [Full Text] [Related]  

  • 58. Treating acute exacerbations of chronic bronchitis in the face of antibiotic resistance.
    Adams SG; Anzueto A
    Cleve Clin J Med; 2000 Sep; 67(9):625-8, 631-3. PubMed ID: 10992620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease.
    Watanabe A
    Infection; 1991; 19 Suppl 7():S384-7. PubMed ID: 1804788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaphylactoid reaction to levofloxacin.
    Smythe MA; Cappelletty DM
    Pharmacotherapy; 2000 Dec; 20(12):1520-3. PubMed ID: 11130225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.